Quantitative proteomics in lung cancer
Abstract Lung cancer is the most common cause of cancer-related death worldwide, less than 7% of patients survive 10 years following diagnosis across all stages of lung cancer. Late stage of diagnosis and lack of effective and personalized medicine reflect the need for a better understanding of the...
Main Authors: | Chantal Hoi Yin Cheung, Hsueh-Fen Juan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12929-017-0343-y |
Similar Items
-
Quantitative proteomics characterization of cancer biomarkers and treatment
by: Xiao-Li Yang, et al.
Published: (2021-06-01) -
An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
by: Vipin Kumar, et al.
Published: (2020-09-01) -
Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
by: Yijun Wu, et al.
Published: (2023-09-01) -
Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome
by: Embla Bodén, et al.
Published: (2022-10-01) -
Research Progress of Biomakers Proteomics-based in Lung Cancer
by: Hui XIE, et al.
Published: (2015-06-01)